We are live on ! Find out more
GAMA

Graticule Asia Macro Advisors Portfolio holdings

AUM $649M
This Fund
S&P 500
This Quarter Est. Return
-3.03%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.28B
AUM Growth
+$665M
Cap. Flow
+$610M
Cap. Flow %
47.73%
Top 10 Hldgs %
53.46%
Holding
214
New
48
Increased
16
Reduced
12
Closed
132

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$27M
2
NOC icon
Northrop Grumman
NOC
+$26.4M
3
RTN
Raytheon Company
RTN
+$25.8M
4
LHX icon
L3Harris
LHX
+$20M
5
OA
Orbital ATK, Inc.
OA
+$18.3M

Top Sells

Rank Stock Value
1
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$21.5M
2
ITB icon
iShares US Home Construction ETF
ITB
+$20.1M
3
AGN
Allergan plc
AGN
+$18.6M
4
RSX
VanEck Russia ETF
RSX
+$13.7M
5
AMZN icon
Amazon
AMZN
+$11.9M

Sector Composition

Rank Sector Weight
1 Industrials 8.02%
2 Consumer Discretionary 3.22%
3 Communication Services 2.92%
4 Healthcare 2.06%
5 Technology 1.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GGAL icon
51
Galicia Financial Group
GGAL
$7.99B
$4.41M 0.34%
155,688
+18,571
+14% +$514K
META icon
52
Meta Platforms (Facebook)
META
$1.42T
$4.4M 0.34%
38,599
-19,401
-33% -$2.05M
CME icon
53
CME Group
CME
$96.3B
$4.32M 0.34%
45,000
– –
BMA icon
54
Banco Macro
BMA
$5.88B
$4.17M 0.33%
64,716
+8,336
+15% +$532K
NFLX icon
55
Netflix
NFLX
$299B
$4.09M 0.32%
+400,000
New +$3.93M
NBIX icon
56
CALL
Neurocrine Biosciences
NBIX
$16.8B
$3.96M 0.31%
+100,000
New +$3.97M
BMRN icon
57
BioMarin Pharmaceuticals
BMRN
$11.6B
$3.93M 0.31%
+47,620
New +$3.87M
AGN
58
DELISTED
Allergan plc
AGN
$3.9M 0.31%
14,557
-64,891
-82% -$18.6M
NBIX icon
59
Neurocrine Biosciences
NBIX
$16.8B
$3.68M 0.29%
92,991
-1,594
-2% -$63.3K
ICPT
60
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$3.47M 0.27%
+27,038
New +$3.19M
OLED icon
61
Universal Display
OLED
$3.68B
$3.37M 0.26%
+62,200
New +$3.04M
OLED icon
62
CALL
Universal Display
OLED
$3.68B
$2.71M 0.21%
+50,000
New +$2.44M
ALDR
63
CALL
DELISTED
Alder Biopharmaceuticals
ALDR
$2.45M 0.19%
+100,000
New +$2.32M
LLY icon
64
Eli Lilly
LLY
$1.02T
$1.69M 0.13%
23,529
-276
-1% -$20.9K
ASHR icon
65
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.54B
$1.66M 0.13%
+67,591
New +$1.57M
EWZ icon
66
iShares MSCI Brazil ETF
EWZ
$9.28B
$1.62M 0.13%
+61,739
New +$1.33M
PTLA
67
CALL
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.59M 0.12%
+78,000
New +$2.47M
TGS icon
68
Transportadora de Gas del Sur
TGS
$4.79B
$1.52M 0.12%
269,701
+2,530
+0.9% +$14.4K
TSM icon
69
TSMC
TSM
$2.1T
$1.42M 0.11%
+54,327
New +$1.27M
RDUS
70
DELISTED
Radius Health, Inc.
RDUS
$1.41M 0.11%
+44,920
New +$1.55M
RBS.PRT
71
DELISTED
ROYAL BANK OF SCOTLAND GRP PLS (THE) SPONS ADR REPSTG PFD
RBS.PRT
$714K 0.06%
28,050
– –
SRPT icon
72
CALL
Sarepta Therapeutics
SRPT
$1.57B
$683K 0.05%
+35,000
New +$612K
XBI icon
73
State Street SPDR S&P Biotech ETF
XBI
$9.95B
$543K 0.04%
10,512
+10,312
+5,156% +$536K
RCKT icon
74
Rocket Pharmaceuticals
RCKT
$340M
$492K 0.04%
16,629
-20,371
-55% -$611K
RBS.PRS.CL
75
DELISTED
The Royal Bank Of Scotland Group
RBS.PRS.CL
$390K 0.03%
15,650
– –
1 2
3
4 5

Similar funds

TWP
Tyche Wealth Partners Plano, Texas $648M AUM 20.17% 1-Year Est. Return
ACA
Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return
CCA
Carrera Capital Advisors Troy, Michigan $649M AUM 19.82% 1-Year Est. Return
SCM
Stevens Capital Management Radnor, Pennsylvania $649M AUM 27.37% 1-Year Est. Return
CAAM
Cornerstone Advisors Asset Management Bethlehem, Pennsylvania $648M AUM 11.43% 1-Year Est. Return
RK
Rather & Kittrell Knoxville, Tennessee $648M AUM 14.68% 1-Year Est. Return
PCM
Primavera Capital Management George Town, Cayman Islands $648M AUM 6.1% 1-Year Est. Return
ITC
Inspire Trust Company Reno, Nevada $648M AUM 19.45% 1-Year Est. Return

Graticule Asia Macro Advisors's Q1 2016 Portfolio in Review

As of Q1 2016, Graticule Asia Macro Advisors held 214 positions worth $1.28B, up 109% from $612M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Graticule Asia Macro Advisors deployed $610M of net new capital in Q1 2016, opening 48 new positions and adding to 16 existing holdings. Its largest new stake was L3Harris: 249,882 shares worth $19.5M.

By sector, the portfolio is most concentrated in Industrials at 8% of assets, down from 10% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Allergan plc, an estimated $18.6M trimmed.

  • Graticule Asia Macro Advisors's largest Q1 2016 buy was L3Harris: 249,882 shares worth $19.5M.
  • Graticule Asia Macro Advisors added most to Alibaba in Q1 2016, an estimated $27M increase.
  • Graticule Asia Macro Advisors's biggest Q1 2016 reduction was Allergan plc, cutting an estimated $18.6M.
  • Graticule Asia Macro Advisors fully exited iShares 7-10 Year Treasury Bond ETF in Q1 2016, selling an estimated $21.5M.
  • Graticule Asia Macro Advisors's ten largest holdings make up 53% of its $1.28B portfolio in Q1 2016.
  • Graticule Asia Macro Advisors opened 48 new positions and closed 132 in Q1 2016.
  • Graticule Asia Macro Advisors's portfolio value rose 109% quarter-over-quarter to $1.28B.

Based on Graticule Asia Macro Advisors's 13F filing for Q1 2016, filed 13 May 2016.